Pre-Clinical Equipment In Australasia
-
PremiumManufactured by Environics, Inc.based in USA
The Environics® Series Reduced Oxygen Breathing Device 3 (ROBD3) is the newest in our line of systems that simulate altitude exposure and can be utilized for both research and hypoxia training. It is customizable for expanded research capabilities, including the addition of CO2. A large touch screen UI makes for simplified operation and on screen viewing during and after ...
-
PremiumManufactured by Environics, Inc.based in USA
The Environics® Series Reduced Oxygen Breathing Device 2 (ROBD2) simulates altitude exposure and can be utilized for both research and hypoxia training. The U. S. Military currently uses the ROBD2 to train aircrew to recognize the signs and symptoms of hypoxia and to perform the appropriate emergency procedures and additionally, conducts hypoxia research. In addition to hypoxia ...
-
Manufactured by Pharmaxis Ltdbased in AUSTRALIA
Pharmaxis is developing a topical drug inhibiting all lysyl oxidase family members with potential anti-fibrotic application in severe fibrotic related scarring indications. Skin scarring after events such as accidents, surgery or burns place a substantial physical and psychological burden on ...
-
Manufactured by Agilent Technologies, Inc.based in USA
BioTek Cytation 7 cell imaging multimode reader combines automated digital upright and inverted widefield microscopy with conventional multimode microplate reading. Cytation 7 includes continually variable bandpass monochromators for versatility and performance for general multimode plate reader applications. The inverted microscopy module provides sample visualization and the upright microscopy ...
-
Manufactured by AXT PTY LTDbased in AUSTRALIA
The FF20 CT is a compact, high-resolution computed tomography system, perfectly suited for inspection of small ...
-
Manufactured by Next Science Limitedbased in AUSTRALIA
BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing. While in place, the antimicrobial properties of the gel inhibit the growth of microorganisms in the ...
-
based in AUSTRALIA
AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T cell therapy to treat a far greater range of cancers than the small number of blood cancers that has been achieved today. Under the Collaboration ...
-
Manufactured by Camurus ABbased in SWEDEN
FluidCrysta nanoparticles can resolve bioavailability issues for water and lipid-soluble pharmaceuticals or biodegradation-sensitive drugs, such as peptides and proteins. FluidCrystal nanoparticles are usually water-based and comprise a stable emulsion of nanoparticles with a liquid crystalline structure. Investigational medicinal products based on this technology are administered either ...
-
Manufactured by Cartherics Pty ltdbased in AUSTRALIA
This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer ...
-
based in USA
A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The goal: Treat the condition—not just the symptoms. The Carillon System is designed to work with the natural structure and function of the heart to help treat the condition of FMR as well as the related symptoms. We believe the ...
-
based in AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
-
Manufactured by LISCure Biosciences Inc.based in SOUTH KOREA
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...
-
based in AUSTRALIA
DEP® docetaxel is an enhanced version of docetaxel (Taxotere®) – widely used for breast, lung & prostate cancer. Docetaxel (Taxotere®) is a commonly used chemotherapy agent despite having multiple US FDA “Black Box” warnings. DEP® docetaxel is a detergent free, aqueous formulation of docetaxel. ...
-
Manufactured by Mesoblast Ltd.based in AUSTRALIA
MPC-06-ID is a Phase 3 product candidate for the treatment of chronic low back pain caused by disc degeneration (CLBP). It is being developed for patients who have exhausted conservative treatment options, may have failed epidural steroid injections and have no further treatment option other than invasive and costly surgical ...
-
Manufactured by Strathkelvin Instruments Limitedbased in UNITED KINGDOM
SI021 - FEP Membranes, 15 in the ...
-
based in AUSTRALIA
CHM 2101 (CDH17 CAR T) is an optimized 3rd generation CAR T cell therapy that is the first to target ...
-
Manufactured by Avaniabased in AUSTRALIA
The right in vitro diagnostic (IVD) device can streamline clinical trials and expedite personalized patient care. We deliver world-class assistance for your IVD device development. We’ll help you build out effective research studies and protocols designed to validate algorithm reliability and ...
-
Manufactured by Field Orthopaedicsbased in AUSTRALIA
The management of small fractures in the hand and wrist is difficult due to the small size, fragile nature, and importance of accurate reduction. The requirement to use clamps and forceps while maintaining position for implant preparation and insertion is challenging. The fully cannulated Micro Screw system is designed to address these challenges and make the management of small fractures easier. ...
-
Manufactured by BioDiem Ltd.based in AUSTRALIA
BDM-I: Addressing market need for next-generation antimicrobials. Infectious diseases often dominate the media headlines, including rising antibiotic resistance and fear of “super bugs”. One serious problem facing the global community is that anti-infective treatments that were once effective now cannot be relied upon. There are some strains of infections including tuberculosis, blood ...
-
Manufactured by Pharmaxis Ltdbased in AUSTRALIA
Pharmaxis' first commercial product, Aridol is an innovative lung function test designed to help doctors diagnose and manage asthma by detecting active airway inflammation through measuring airway hyper-responsiveness. Patients inhale increasing doses of Aridol via a simple hand-held device. Respiratory clinicians administering the test measure the patient's lung function to identify airway ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you